Zepp Health Corporation
NYSE:ZEPPConsumer Electronics
-$0.03 today
- Market cap
- $50.84M
- Beta
- 1.78
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$282.07
Volume 0.04M
Average 0.13M
ZEPP Other Non-current Assets
Long-term assets not reported separately.
Zepp Health CorporationNYSE: ZEPP
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets falls 23.8% from a year ago
Other non-current assets stood at CN¥24.28M at the end of Q1 FY2026, down 23.8% from a year earlier and down 6.6% from the prior quarter. Over 3 fiscal years it compounded at -19.4% a year.
Context
- Other non-current assets amounted to 0.7% of total assets at the end of Q1 FY2026, down 0.2 pp from a year earlier.
- Other non-current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps falling in the next quarterly balance sheet after a -23.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
CNY · from the balance sheet
- Latest · FY2025
- 26M CNY
- Year-over-year change
- -22.7%
- 4-year CAGR
- +7.4%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26M | -22.7% |
| FY2024 | 2024-12-31 | 33.63M | -51.1% |
| FY2023 | 2023-12-31 | 68.7M | +38.3% |
| FY2022 | 2022-12-31 | 49.67M | +153.8% |
| FY2021 | 2021-12-31 | 19.57M | — |
Other Non-current Assets vs competitors
How ZEPP compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -23.8% is the lowest of 7, against a peer median of +15.5%.
- Other non-current assets amounts to 0.7% of total assets for ZEPP, versus a peer median of 7.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $101.43M USD | +0.7% | +17.7% | 7.2% | |
| Mar 2026 | $81.66M USD | +5091.4% | -15.2% | 77.4% | |
| Mar 2026 | $66.13M USD | -22.3% | -1.3% | 23.5% | |
| Mar 2026 | CN¥24.28M CNY | -23.8% | -19.4% | 0.7% | |
| Mar 2026 | $15.47M USD | -2.3% | -57.4% | 2.0% | |
SVCOSilvaco Group, Inc. Common Stock | Mar 2026 | $14.91M USD | +30.2% | +91.6% | 13.4% |
| Mar 2026 | $1.78M USD | +71.3% | +20.0% | 0.9% | |
| Dec 2025 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ZEPP) | — | +15.5% | +8.2% | 7.2% | |
Competitors are the stored peer set for ZEPP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.51B | 959.38M | 995.09M | 808.23M | 789.7M |
| Short-term Investments | 24.32M | 33.82M | 36.5M | 7.28M | 0 |
| Net Receivables | 1.09B | 857.83M | 580.63M | 577.66M | 514.47M |
| Inventory | 1.26B | 1.01B | 601.38M | 414.51M | 508.76M |
| Other Current Assets | 815.05K | 3.17M | 1.63M | 1.7M | 239.59M |
| Total Current Assets | 3.93B | 2.92B | 2.24B | 1.84B | 2.05B |
| Property, Plant & Equipment (Net) | 242.02M | 163.79M | 111.56M | 75.59M | 53.28M |
| Goodwill | 60.98M | 65.13M | 67.87M | 69.93M | 67M |
| Intangible Assets | 135.42M | 121.53M | 69.91M | 51.76M | 95.18M |
| Long-term Investments | 1.55B | 1.67B | 1.71B | 1.66B | 1.55B |
| Tax Assets | 143.25M | 207.17M | 229.53M | 127.47M | 110.08M |
| Other Non-current Assets | 19.57M | 49.67M | 68.7M | 33.63M | 26M |
| Total Non-current Assets | 2.15B | 2.28B | 2.26B | 2.02B | 1.9B |
| Total Assets | 6.08B | 5.19B | 4.5B | 3.86B | 3.95B |
| Account Payables | 1.32B | 450.04M | 264.14M | 372.8M | 564.78M |
| Short-term Debt | 550.43M | 996.26M | 513.98M | 765.56M | 1.17B |
| Tax Payables | 2.6M | 2.72M | 3.64M | 4.16M | 0 |
| Deferred Revenue | 92.1M | 62.39M | 55.51M | 37.54M | 531.44K |
| Other Current Liabilities | 146.82M | 107.87M | 244.39M | 232.37M | 266.99M |
| Total Current Liabilities | 2.15B | 1.64B | 1.1B | 1.43B | 2.01B |
| Long-term Debt | 726M | 674.4M | 850.23M | 549.17M | 415.89M |
| Deferred Tax Liabilities | 26.88M | 35.04M | 29.53M | 22.75M | 18.69M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 174.85M | 160.27M | 1.91M | 970.73K | 1.46M |
| Total Non-current Liabilities | 998.75M | 900.94M | 904.32M | 587.54M | 443.75M |
| Total Liabilities | 3.15B | 2.55B | 2B | 2.01B | 2.45B |
| Common Stock | 158.81K | 159.67K | 184.19K | 189.76K | 181.81K |
| Retained Earnings | 1.27B | 929.32M | 739.23M | 208.88M | (80.07M) |
| Accumulated OCI | 29.24M | 104.28M | (99.23M) | (293.25M) | (278.87M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | (14) |
| Minority Interest | 13.08M | 12.22M | 13.25M | 8.31M | 0 |
| Total Equity | 2.93B | 2.65B | 2.5B | 1.84B | 1.5B |
| Total Debt | 1.35B | 1.7B | 1.39B | 1.33B | 1.59B |
| Net Debt | (160.3M) | 742.51M | 391.76M | 521.15M | 804.83M |
Zepp Health Corporation
NYSE:ZEPP
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.